Clinical trial
Retinal Microvascularization and Cardiovascular Diseases
NCT03551717 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retinal Microvascularization and Cardiovascular Diseases
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 14, 2018
- Completion date
- April 19, 2019
- Enrollment
- 155 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
high cardiovascular risk patients, low cardiovascular risk patients